Cue Health on Tuesday afternoon announced a whopping year-over-year uptick in revenues for the fourth quarter, beating the consensus Wall Street estimate.

Liquid biopsy performed on serum samples taken from breast cancer patients can provide increasingly accurate information on cancer progression and enable earlier detection of cancer recurrence, a new study from the University of Eastern Finland and Kuopio University Hospital shows.

On March 30, Rendu Biotechnology was listed on SSE Star Market, stock code: 688193. The issue price is 72.65 per share, and a total of 136,100 shares were issued.

Thermo Fisher Scientific said on Tuesday that it received CE-IVD marking for the Ion Torrent Genexus Dx Integrated Sequencer this month and is making the platform commercially available for diagnostic testing and clinical research.

Beckman Coulter Life Sciences announced on Tuesday that it has inked an application development agreement with in vitro diagnostic company AmoyDx.

On March 26, Beckman Coulter and Biolihe held a grand strategic cooperation signing ceremony in the cloud.

University of Notre Dame researchers have discovered another way tumor cells transfer genetic material to other cells in their microenvironment, causing cancer to spread.

Visby Medical announced on Friday that it will execute a $25.5 million contract option with the Office of the Assistant Secretary for Preparedness and Response to develop an at-home version of its handheld, PCR-based test for influenza and COVID-19.

On March 23, after review by the State Food and Drug Administration, two COVID-19 antigen detection reagent products were approved. As of March 23, the State Food and Drug Administration has approved 19 new coronavirus antigen detection reagent products.

Roche said on Friday that it has entered into a collaboration with Bristol Myers Squibb to develop and deploy two assays with new digital pathology algorithms for clinical trials.

Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology.

On March 21, the British Gov. web announced that three procurement contracts for COVID-19 antigen reagents.

California diagnostic firm Innova Medical Group announced on Wednesday that its Innova SARS-CoV-2 Antigen Rapid Qualitative Test has received CE marking for self-testing.

Researchers at Queen Mary University of London have developed the world’s first PCR test for mouth cancer.

On March 23, 2022, AutoBio’s SARS-CoV-2 Ag Rapid Home Test successfully passed the European clinical assessment and the audit of the notified institution, obtained the EU CE certificate.